Columbus Venture Partners to launch third biotech fund of up to EUR 100m at the beginning of 2021
Columbus Venture Partners prepara su tercer fondo biotech de hasta EUR 100m para principios de 2021
Intel ID : 307270
|
||||
|
||||
| Intel ID | 307270 | |
| Value | EUR 100,00m (Approx.) | |
| Native Currency | Euro (EUR) | |
|
Financial Data - Columbus Venture Partners
(31 Dec 2023) |
Revenue: EUR 6,71m EBITDA: EUR 4,58m People: 15 |
|
| Date |
 |
|
| Country | |
|
| Geography |  |
|
| Subsector (Old TTR Sectors) |
|
|
| Type |
|
|
| Intel Grade |
|
|
| Source |
|
|
| Tags | |
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
25.01.10 Venture Capital 25 Financial Services / 25.01 Banking & Investment |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Radar
| Date | Title | Type | Intel Grade | Country | Subsector | ||
|
|
|
|
|
|
|
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.